Excipient producer also are expanding in related pharmaceutical applications. For example, Huber Engineered Materials (HEM),
a division of J.M. Huber Corp., is expanding its Quincy, Illinois, manufacturing operations to increase capacity for calcium
carbonate granulation production. The new addition is expected to become operational in the second quarter of 2012 and generate
nearly 10,000 metric tons of calcium carbonate granulation annually to serve the dietary supplement and pharmaceutical markets.
The calcium carbonate granulation to be manufactured in Quincy will mirror that of the granulation line at HEM's plant in
Modesto, California. The company recently received its California drug-manufacturing license for the Modesto facility and
will continue to produce APIs at Quincy. Huber also produces calcium carbonate powder.
Huber became a granulator of calcium carbonate and oyster-shell powders with its 2003 acquisition of Micro Powders and Braig
and added to its portfolio with the addition of West Coast Ingredients in 2006. The company added to its particle-engineering
capacity in 2007 with the addition of fluid-bed granulation and trituration capabilities.
Patricia Van Arnum is a senior editor at Pharmaceutical Technology, 485 Route One South, Bldg F, First Floor, Iselin, NJ 08830 tel. 732.346.3072, email@example.com
1. P. Van Arnum, "Global Pharma Market Expected to Reach $1 Trillion," Pharm. Technol. Sourcing and Management,
7 (6), June 2011.
2. Lubrizol, "Pharmaceutical Polymers for Oral Solid Dosage Forms" Product Literature (Wickliffe, OH), 2011.